Guangdong Biolight Meditech Co Ltd (300246) - Total Assets
Based on the latest financial reports, Guangdong Biolight Meditech Co Ltd (300246) holds total assets worth CN¥2.46 Billion CNY (≈ $359.82 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check total reinvestment intensity of Guangdong Biolight Meditech Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Guangdong Biolight Meditech Co Ltd - Total Assets Trend (2008–2025)
This chart illustrates how Guangdong Biolight Meditech Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore 300246 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Guangdong Biolight Meditech Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Guangdong Biolight Meditech Co Ltd's total assets of CN¥2.46 Billion consist of 50.6% current assets and 49.4% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 26.8% |
| Accounts Receivable | CN¥242.14 Million | 9.6% |
| Inventory | CN¥287.82 Million | 11.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥116.51 Million | 4.6% |
| Goodwill | CN¥15.49 Million | 0.6% |
Asset Composition Trend (2008–2025)
This chart illustrates how Guangdong Biolight Meditech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Guangdong Biolight Meditech Co Ltd (300246) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guangdong Biolight Meditech Co Ltd's current assets represent 50.6% of total assets in 2025, a decrease from 78.9% in 2008.
- Cash Position: Cash and equivalents constituted 26.8% of total assets in 2025, up from 18.3% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, an increase from 1.0% in 2008.
- Asset Diversification: The largest asset category is inventory at 11.4% of total assets.
Guangdong Biolight Meditech Co Ltd Competitors by Total Assets
Key competitors of Guangdong Biolight Meditech Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $90.55 Million |
|
Medacta Group SA
SW:MOVE
|
Switzerland | CHF860.76 Million |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Xiangyu Medical Co. Ltd. A
SHG:688626
|
China | CN¥3.27 Billion |
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.17 Billion |
Guangdong Biolight Meditech Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.46 | 2.28 | 1.95 |
| Quick Ratio | 1.08 | 1.86 | 1.60 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥382.61 Million | CN¥687.01 Million | CN¥416.70 Million |
Guangdong Biolight Meditech Co Ltd - Advanced Valuation Insights
This section examines the relationship between Guangdong Biolight Meditech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.81 |
| Latest Market Cap to Assets Ratio | 0.29 |
| Asset Growth Rate (YoY) | 0.9% |
| Total Assets | CN¥2.52 Billion |
| Market Capitalization | $735.30 Million USD |
Valuation Analysis
Below Book Valuation: The market values Guangdong Biolight Meditech Co Ltd's assets below their book value (0.29x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Guangdong Biolight Meditech Co Ltd's assets grew by 0.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Guangdong Biolight Meditech Co Ltd (2008–2025)
The table below shows the annual total assets of Guangdong Biolight Meditech Co Ltd from 2008 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.52 Billion ≈ $369.09 Million |
+0.94% |
| 2024-12-31 | CN¥2.50 Billion ≈ $365.66 Million |
-1.40% |
| 2023-12-31 | CN¥2.53 Billion ≈ $370.86 Million |
+3.92% |
| 2022-12-31 | CN¥2.44 Billion ≈ $356.88 Million |
+41.83% |
| 2021-12-31 | CN¥1.72 Billion ≈ $251.62 Million |
+6.99% |
| 2020-12-31 | CN¥1.61 Billion ≈ $235.18 Million |
+67.16% |
| 2019-12-31 | CN¥961.46 Million ≈ $140.69 Million |
+4.72% |
| 2018-12-31 | CN¥918.15 Million ≈ $134.35 Million |
+14.74% |
| 2017-12-31 | CN¥800.22 Million ≈ $117.10 Million |
+16.55% |
| 2016-12-31 | CN¥686.57 Million ≈ $100.47 Million |
+18.24% |
| 2015-12-31 | CN¥580.65 Million ≈ $84.97 Million |
+11.88% |
| 2014-12-31 | CN¥519.01 Million ≈ $75.95 Million |
+10.03% |
| 2013-12-31 | CN¥471.72 Million ≈ $69.03 Million |
+8.82% |
| 2012-12-31 | CN¥433.50 Million ≈ $63.43 Million |
+9.34% |
| 2011-12-31 | CN¥396.48 Million ≈ $58.02 Million |
+209.73% |
| 2010-12-31 | CN¥128.01 Million ≈ $18.73 Million |
+23.82% |
| 2009-12-31 | CN¥103.38 Million ≈ $15.13 Million |
+31.86% |
| 2008-12-31 | CN¥78.41 Million ≈ $11.47 Million |
-- |
About Guangdong Biolight Meditech Co Ltd
Guangdong Biolight Meditech Co., Ltd. engages in the research and development, production, sale, and service of medical devices products and solutions in China. It operates in two segments, Life Information and Support, and Kidney Disease. The company offers emergency and critical care monitor, subcritical care monitor, general ward monitor, outpatient monitor, neonatal monitor, infusion pump, el… Read more